We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Diagnosing Ovarian Cancer

By HospiMedica staff writers
Posted on 31 Aug 2005
A new study has shown that many women diagnosed with ovarian cancer had complained of symptoms at least four months before their diagnosis but only about one quarter were given any diagnostic tests in a timely manner. More...


Ovarian cancer is considered a silent killer since it comes to the attention of a doctor only in its late stages, when prognosis is poor. Adding to this deadly pattern is the fact that it is a fast-growing tumor, often progressing from early to advanced disease in as little as a year. Lately, there has been increasing evidence that patients may exhibit symptoms many months before diagnosis and advanced disease occur, suggesting that earlier diagnosis is possible.

In the new study, women with ovarian cancer were found to be at least twice as likely to present to a doctor with abdominal swelling or pelvic pain as early as 12 months before diagnosis. As early as nine months before diagnosis, they were likely to complain of pelvic pain. About 40% had one or more doctor visits for symptoms between 36 and four months before diagnosis, but only 25% had diagnostic pelvic imaging or CA125 serum tests during that period. Most received abdominal imaging or diagnostic gastrointestinal studies, less likely to establish the correct diagnosis. In contrast, 54% of ovarian cancer patients received pelvic imaging or CA125 serum testing within three months before their ovarian cancer was diagnosed.

"Our findings suggest that ovarian cancer could be diagnosed earlier in some patients whose diagnosis is currently delayed by at least four months because physicians order abdominal imaging or perform gastrointestinal procedures before they order a test more likely to diagnose ovarian cancer, such as pelvic imaging and/or CA125,” concluded the authors of the study.

The study was conducted by Lloyd H. Smith, M.D., Ph.D., of the University of California at Davis School of Medicine (Sacramento, USA), and colleagues. They compared diagnosis codes and claims for diagnostic procedures among 1,985 elderly women with ovarian cancer, 6,024 elderly women with localized breast cancer, and 10,941 age-matched women without cancer. The results of the study were reported in the August 22, 2005, online issue of Cancer (Wiley InterScience).






Related Links:
U. of California Davis School of Medicine

Platinum Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
Disposable Protective Suit For Medical Use
Disposable Protective Suit For Medical Use
Infrared Digital Thermometer
R1B1
Morcellator
TCM 3000 BL
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.